Will Broadcom Stock Recover After Its Guidance Disappointment, Or Should You Cut Your Losses?

Broadcom reported strong fiscal Q2 results, with revenue up 48% year over year to $22.19 billion and adjusted EPS of $2.44, both slightly ahead of estimates. However, the stock fell more than 14% intraday as investors focused on AI chip revenue guidance of about $16 billion for Q3 versus the $17.2 billion consensus and the company’s decision to merely reaffirm its $100 billion AI revenue target for fiscal 2027. The selloff appears tied more to elevated expectations and sentiment than to deteriorating fundamentals.

Analysis

The market’s reaction reads less like a fundamental reset and more like a positioning air-pocket in a crowded AI winner. AVGO has become a proxy for “AI spend keeps compounding every quarter,” so even a modest deceleration in the slope of revisions can trigger de-risking across semi beta, especially in names where expectations were already levered by momentum and dealer hedging. That explains why weaker follow-through can spill into AMD, INTC, and MU even though the direct read-through to their businesses is uneven.

The key second-order issue is that Broadcom’s AI franchise is increasingly judged on cadence, not level. Management’s refusal to ratchet up the long-dated target is rational capital allocation, but in the current tape it signals that hyperscaler demand is still massive yet no longer accelerating at the same pace investors have internalized. That matters because the sector has been priced for repeated upside surprises; once that reflex breaks, multiple compression can occur faster than fundamentals deteriorate.

Near term, the risk is less a demand collapse than a sentiment unwind and a temporary contraction in the AI infrastructure basket’s valuation multiple. Over the next 1-3 months, any confirmation that supply is booked through 2027 but not meaningfully extended beyond that will reinforce the idea that growth visibility is strong but finite, which should cap upside in the most crowded names. The contrarian read is that this is constructive: conservative guidance can reduce the probability of a harsher 2026-27 reset, making the stock more attractive on further weakness than on any intraday bounce.

The cleanest edge is to own AVGO only if you can tolerate a lower multiple regime while fading the beta-heavy sympathy trade. If the market is punishing merely for not exceeding whisper numbers, that creates opportunity in relative value rather than outright direction.

Key Decisions for Investors

• Buy AVGO on further 3-5% post-event weakness with a 3-6 month horizon; target a re-rating back toward its long-run forward P/E band midpoint, but size modestly because multiple compression can persist even if fundamentals remain intact.
• Pair trade: long AVGO / short AMD for 4-8 weeks. AVGO has clearer cash-flow visibility and less balance-sheet sensitivity to AI capex sentiment; AMD is more exposed to expectation resets and narrative-driven downside if AI enthusiasm cools.
• Short MU against a basket of AI infrastructure leaders for 1-2 months. If the market shifts from growth acceleration to digestion, memory names typically underperform as investors question the durability of the next upcycle.
• Sell short-dated downside put spreads on AVGO only after the first post-earnings flush stabilizes; the setup favors volatility normalization rather than a fundamental collapse, but avoid naked short puts until implied vol resets lower.
• Avoid chasing NVDA/AMD on sympathy strength until the market proves AI spending revisions are re-accelerating; the risk-reward is poor when the sector is trading on whisper-number calibration rather than actual incremental orders.